HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

rhamnogalacturonan II

structurally different from rhamnogalacturonan I; consists of appx 60 glycosyl residues including 2-O-methyl fucosyl, 2-O-methyl xylosyl, apiosyl & 3-C-carboxy-5-deoxy-L-xylosyl
Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Hwang, Dahyun: 1 article (06/2017)
2. Kim, Tae Young: 1 article (06/2017)
3. Park, Hye-Ryung: 1 article (06/2017)
4. Shin, Kwang-Soon: 1 article (06/2017)
5. Suh, Hyung-Joo: 1 article (06/2017)
6. Yu, Kwang-Won: 1 article (06/2017)
7. Chen, Hubiao: 1 article (01/2017)
8. Chen, Qilei: 1 article (01/2017)
9. Tang, Yina: 1 article (01/2017)
10. Yi, Tao: 1 article (01/2017)

Related Diseases

1. Neoplasms (Cancer)
2. Lymphoma (Lymphomas)
3. Infections
4. Hyperglycemia

Related Drugs and Biologics

1. Polysaccharides (Glycans)
2. Toll-Like Receptor 4
3. Interleukin-12 (IL 12)
4. Pectins
5. Ovalbumin
6. Interleukins
7. Borates
8. Acids
9. Sugars
10. 3-C-carboxy-5-deoxyxylose